Found 11 matching trials
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over N/A The aim of the study is to compare, in real life, the risk benefit (includi...
Show More Location
Assistance Publique Hôpitaux de Paris
Learn More & Join Trial
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion PHASE3 A study for patients with abnormal heart rhythm (atrial fibrillation) who n...
Show More Location
Multiple Locations
Learn More & Join Trial
Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events N/A The main objective of this project is to evaluate savings in direct costs a...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Outcomes From Patient Self-management of Antivitamin K Treatment N/A ORION is a retrospective, observational, one center study to evaluate the i...
Show More Location
Hspital de la Santa Creu i Sant Pau
Learn More & Join Trial
Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care N/A This study will characterize patients with ischemic stroke, a condition whi...
Show More Learn More & Join Trial
Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding. PHASE4 SUMMARY
1.0. Type of Application: Clinical trial comparing two treatments ...
Show More Location
Hospital de la Santa Creu i Sant Pau
Learn More & Join Trial
Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) N/A CORONA is a retrospective, observational, one center study to investigate t...
Show More Location
Hospital de la Santa Creu i Sant Pau
Learn More & Join Trial
SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism PHASE3 Patients who have a pulmonary embolism (blood clot in the lung) will be tre...
Show More Location
Jerry L. Pettic VA Medical Center
Learn More & Join Trial
Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation PHASE3 There are insufficient data on the safety and efficacy of edoxaban therapy ...
Show More Learn More & Join Trial
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS N/A The goal of this registry is to gather more information on the efficacy and...
Show More Location
Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires
Learn More & Join Trial